Lonza tweaks E.coli expression system; denies takeover rumours
Lonza claims a new selection technology to its microbial protein expression system will improve yields and boost efficiency.
Archives for October 29, 2012
News from Lonza, DSM, Ark and AMRI
Outsourcing-pharma.com presents a roundup of contract manufacturing news with deals for Lonza, DSM and Ark Therapeutics and an expanded agreement with Shire for AMRI.
Patheon to buy Banner Pharmacaps for $255m
Canadian CMO Patheon will buy softgel specialist Banner Pharmacaps, moving forward with its plan to build in the oral dose delivery sector.